Glycotherapeutics; a new class of treatment for alphavirus-induced musculoskeletal disease [ 2015 - ]

Research Grant

Researchers: Dr Lara Herrero (Principal investigator)

Brief description The hallmark of alphavirus disease is crippling pain and joint arthritis, which often has an extended duration. Currently there is no licenced specific treatment for alphavirus disease and the increasing spread of infection highlights an urgent need for therapeutic intervention strategies. This grant looks at the potential of pentosan polysulfate as a promising drug-repurposing candidate for the treatment of alphavirus-induced arthritis.

Funding Amount $435,785.00

Funding Scheme Project Grants

Notes New Investigator Grant